Provided by Katherine Watson
For the fourth consecutive year, Northside Hospital’s Blood and Marrow Transplant (BMT) Program has been reported as having among the best survival outcomes in the country for related and unrelated bone marrow transplants.
The data was reported by the National Marrow Donor Program (NMDP), the federally funded organization that facilitates most unrelated bone marrow transplants in the United States. The most recently reported data spans from years 2008 through 2010.
Transplanting healthy marrow may be the best and only hope of a cure for life-threatening diseases such as leukemia, lymphoma and other blood disorders, a media statement said. The BMT Program at Northside is one of the largest and most comprehensive programs in the nation, serving patients who require bone marrow or stem cell transplants. Patients don’t need to travel far to have access to the full range of available hematopoietic transplants, including those from matched related, matched unrelated and haploidentical donors, and cord blood transplants. All services are conveniently located at Northside’s Atlanta campus.
In 2012, 184 transplants were performed at Northside, placing the hospital among the top BMT programs in the nation in terms of volume. The one-year survival of patients transplanted at Northside was 78 percent, among the best of any BMT program in the country and exceeding the survival expected by the NMDP for Northside. Northside is one of only two transplant programs in the country (out of 130), who have performed significantly better than their expected range for the past four consecutive reporting cycles.
"At Northside, we are committed to providing our patients with outstanding clinical care as demonstrated by our patient-centered, comprehensive quality management program," said H. Kent Holland, M.D., in the announcement. Holland is medical director, BMT Program at Northside Hospital.